“Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis” (2022) Biomolecules and Biomedicine, 22(6), pp. 912–922. doi:10.17305/bjbms.2022.7309.